NBN: Options for Cancer Treatment
Cancer Treatment for People with an Inherited Mutation
People with an NBN mutation who have been diagnosed with cancer may benefit from testing and may qualify for clinical trials looking for more effective treatments for cancer.
PARP inhibitors for prostate cancer
The Talzenna () has received FDA-approval to treat men with metastatic, , who have a mutation in NBN or other genes linked to a certain type of damage repair.
Other types of cancer
Currently there are no other cancer treatments approved specifically for people with a NBN mutation, nor guidelines for treating cancer specifically for people with a NBN mutation. To learn more about standard of care treatment options for specific types of cancer, visit our section on Cancer Treatment by Cancer Type. You may also consider enrolling in a clinical trial studying which treatments work best for people with an inherited NBN mutation.
